The impact of caffeic acid loaded solid lipid nanoparticles on cancer treatment

Current Nanoscience

Volumn 9, Issue 6, 2013, Pages 698-703

  Mehtap Kutlu, H ^a   Genç, Lütfi ^a   Güney, Gamze ^b  

^a ANADOLU UNIVERSITY   (Turkey)

^b SAKARYA UNIVERSITY   (Turkey)

Author keywords

Caffeic acid (CA); Cancer; Drug delivery; Solid lipid nanoparticles (SLN)

Indexed keywords

EID: 84894068394     PISSN: 15734137     EISSN: 18756786     Source Type: Journal    
DOI: 10.2174/15734137113099990077     Document Type: Article

References (14)

1. Koyu, A.; Ozgüner, F.; Yi{dotless}lmaz, H.R.; Cesur, G.; Özçelik, N. The protective effect of caffeic acid phenethyl ester (CAPE) on oxidative stress in rat liver. Toxicol. Ind. Health, 2009, 25, 429.
2. Jiang, H.Y.; An, C.C.; Feng, J.; Ci, Y.X.; Sugisawa, A.; Izumitani, M.; Chen, Z.L. Effect of Caffeic acid on the Tumor Cells U937 Evaluated by an Electrochemical Voltammetric Method. Chin. Chem. Lett., 1999, 10(9), 781-782.
3. Bhat, S.H.; Azmi, A.S.; Hadi, S.M. Prooxidant DNA breakage induced by caffeic acid in human peripheral lymphocytes: Involvement of endogenous copper and a putative mechanism for anticancer properties. Toxicol. Appl. Pharmacol., 2007, 218, 249-255.
4. Schwarz, W.M.; Lucks, J.S.; Muller, R.H. Solid lipid nanoparticles (SLN) for controlled drug delivery: I. Production, characterization and sterilization. J. Control. Release, 1994, 30(1), 83-96.
5. Schwarz, W.M. Solid lipid nanoparticles (SLN) for controlled drug delivery: II. Drug incorporation and physicochemical characterization. J. Microencapsul., 1999, 16(2), 205-213.
6. Muller, R.H.; Radtke, M.; Wissing, S.A. Lipid nanoparticles (SLN and NLC) for drug delivery, in: Nanoparticles for Pharmaceutical Applications, Kumar, R.; Tabata, Y.; Domb, A. (Eds.), American Scientific Publishers, 2004, pp. 43-56.
7. Ochekpe, N.A.; Olorunfemi, P.; Ngwuluka, N. Nanotechnology and Drug Delivery Part 2: Nanostructures for Drug Delivery. Trop. J. Pharm. Res., 2009, 8(3), 275-287.
8. Souto, E.B.; Wissing, S.A.; Barbosa, C.M.; Muller, R.H. Preparation and characterization of ketoconazole-loaded lipid nanoparticles (SLN & NLC). Int. Symp. Control. Rel. Bioact. Mater., 2004, 31.
9. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Method, 1983, 65, 55-63.
10. Huang, M.; Ma, W.; Yen, P.; Xie, J.; Han, J.; Frenkel, K.; Grunberg, D.; Conney, A.H. Inhibitory effects of caffeic acid phenethyl ester (CAPE) on 12-0-tetradecanoylphorbol-13-acetate-induced tumor promotion in Mouse skin and the sythesis of DNA, RNA and protein in Hela cells. Carcinogenesis, 1996, 17(4), 761-765.
11. Chung, T.; Moon, S.; Chang, Y.; Ko, J.; Lee, Y.; Cho, G.; Kim, S.; Kim, J.; Kim, C. Novel and therapeutic effect of caffeic acid and caffeic acid phenly ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J., 2004, 18, 1670-1681.
12. Kang, K.; Lee, K.H.; Zhang, R.; Plao, M.; Chae, S.; Kim, K.N.; Jeon, Y.J.; Park, D.B.; You, H.J.; Hyun, J.W. Caffeic Acid Protects Hydrogen Peroxide Induced Cell Damage in WI-38 Human Lung Fibroblast Cells. Biol. Pharm. Bull., 2006, 29(9), 1820-1824.
13. Bose, J.S.; Gangan, V.; Jain, S.K.; Manna, S.K. Novel caffeic acid ester derivative induced apoptosis by expressing Fasl and downregulating NFKappa B: Potentiation of Cell Death Mediated by Chemotherapeutic Agent. J. Cell. Physiol., 2009, 218, 653-662.
14. Muller, R.H.; Mader, K.; Gohla, S. Solid Lipid Nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur. J. Pharm. Biopharm., 2000, 50, 161-177.